233 related articles for article (PubMed ID: 23247197)
1. Ku70 acetylation and modulation of c-Myc/ATF4/CHOP signaling axis by SIRT1 inhibition lead to sensitization of HepG2 cells to TRAIL through induction of DR5 and down-regulation of c-FLIP.
Kim MJ; Hong KS; Kim HB; Lee SH; Bae JH; Kim DW; Dao TT; Oh WK; Kang CD; Kim SH
Int J Biochem Cell Biol; 2013 Mar; 45(3):711-23. PubMed ID: 23247197
[TBL] [Abstract][Full Text] [Related]
2. CCAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction and ubiquitin/proteasome-mediated cellular FLICE-inhibitory protein down-regulation contribute to enhancement of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by dimethyl-celecoxib in human non small-cell lung cancer cells.
Chen S; Liu X; Yue P; Schönthal AH; Khuri FR; Sun SY
Mol Pharmacol; 2007 Nov; 72(5):1269-79. PubMed ID: 17684158
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of euchromatin histone-lysine N-methyltransferase 2 sensitizes breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through reactive oxygen species-mediated activating transcription factor 4-C/EBP homologous protein-death receptor 5 pathway activation.
Kim SY; Hong M; Heo SH; Park S; Kwon TK; Sung YH; Oh Y; Lee S; Yi GS; Kim I
Mol Carcinog; 2018 Nov; 57(11):1492-1506. PubMed ID: 29964331
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoid receptor antagonist sensitizes TRAIL-induced apoptosis in renal carcinoma cells through up-regulation of DR5 and down-regulation of c-FLIP(L) and Bcl-2.
Min KJ; Jang JH; Lee JT; Choi KS; Kwon TK
J Mol Med (Berl); 2012 Mar; 90(3):309-19. PubMed ID: 22008998
[TBL] [Abstract][Full Text] [Related]
5. Carnosic acid sensitized TRAIL-mediated apoptosis through down-regulation of c-FLIP and Bcl-2 expression at the post translational levels and CHOP-dependent up-regulation of DR5, Bim, and PUMA expression in human carcinoma caki cells.
Jung KJ; Min KJ; Bae JH; Kwon TK
Oncotarget; 2015 Jan; 6(3):1556-68. PubMed ID: 25596735
[TBL] [Abstract][Full Text] [Related]
6. Salermide up-regulates death receptor 5 expression through the ATF4-ATF3-CHOP axis and leads to apoptosis in human cancer cells.
Liu G; Su L; Hao X; Zhong N; Zhong D; Singhal S; Liu X
J Cell Mol Med; 2012 Jul; 16(7):1618-28. PubMed ID: 21801305
[TBL] [Abstract][Full Text] [Related]
7. Tanshinone IIA Facilitates TRAIL Sensitization by Up-regulating DR5 through the ROS-JNK-CHOP Signaling Axis in Human Ovarian Carcinoma Cell Lines.
Chang CC; Kuan CP; Lin JY; Lai JS; Ho TF
Chem Res Toxicol; 2015 Aug; 28(8):1574-83. PubMed ID: 26203587
[TBL] [Abstract][Full Text] [Related]
8. Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP.
Kim YH; Jung EM; Lee TJ; Kim SH; Choi YH; Park JW; Park JW; Choi KS; Kwon TK
Free Radic Biol Med; 2008 Mar; 44(6):1055-68. PubMed ID: 18164688
[TBL] [Abstract][Full Text] [Related]
9. Withaferin A sensitizes TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP.
Lee TJ; Um HJ; Min do S; Park JW; Choi KS; Kwon TK
Free Radic Biol Med; 2009 Jun; 46(12):1639-49. PubMed ID: 19345731
[TBL] [Abstract][Full Text] [Related]
10. Role of endoplasmic reticulum stress in alpha-TEA mediated TRAIL/DR5 death receptor dependent apoptosis.
Tiwary R; Yu W; Li J; Park SK; Sanders BG; Kline K
PLoS One; 2010 Jul; 5(7):e11865. PubMed ID: 20686688
[TBL] [Abstract][Full Text] [Related]
11. Over-expression of Reticulon 3 (RTN3) enhances TRAIL-mediated apoptosis via up-regulation of death receptor 5 (DR5) and down-regulation of c-FLIP.
Lee JT; Lee TJ; Kim CH; Kim NS; Kwon TK
Cancer Lett; 2009 Jul; 279(2):185-92. PubMed ID: 19250737
[TBL] [Abstract][Full Text] [Related]
12. Quercetin sensitizes human hepatoma cells to TRAIL-induced apoptosis via Sp1-mediated DR5 up-regulation and proteasome-mediated c-FLIPS down-regulation.
Kim JY; Kim EH; Park SS; Lim JH; Kwon TK; Choi KS
J Cell Biochem; 2008 Dec; 105(6):1386-98. PubMed ID: 18980244
[TBL] [Abstract][Full Text] [Related]
13. PPARgamma ligands enhance TRAIL-induced apoptosis through DR5 upregulation and c-FLIP downregulation in human lung cancer cells.
Zou W; Liu X; Yue P; Khuri FR; Sun SY
Cancer Biol Ther; 2007 Jan; 6(1):99-106. PubMed ID: 17172826
[TBL] [Abstract][Full Text] [Related]
14. Direct repression of FLIP expression by c-myc is a major determinant of TRAIL sensitivity.
Ricci MS; Jin Z; Dews M; Yu D; Thomas-Tikhonenko A; Dicker DT; El-Deiry WS
Mol Cell Biol; 2004 Oct; 24(19):8541-55. PubMed ID: 15367674
[TBL] [Abstract][Full Text] [Related]
15. Sensitization of TRAIL-induced apoptosis in human hepatocellular carcinoma HepG2 cells by phytochemicals.
Abou El Naga RN; Azab SS; El-Demerdash E; Shaarawy S; El-Merzabani M; Ammar el-SM
Life Sci; 2013 Mar; 92(10):555-61. PubMed ID: 23352978
[TBL] [Abstract][Full Text] [Related]
16. Isoobtusilactone A sensitizes human hepatoma Hep G2 cells to TRAIL-induced apoptosis via ROS and CHOP-mediated up-regulation of DR5.
Chen CY; Yiin SJ; Hsu JL; Wang WC; Lin SC; Chern CL
J Agric Food Chem; 2012 Apr; 60(13):3533-9. PubMed ID: 22400995
[TBL] [Abstract][Full Text] [Related]
17. Dissecting the roles of DR4, DR5 and c-FLIP in the regulation of geranylgeranyltransferase I inhibition-mediated augmentation of TRAIL-induced apoptosis.
Chen S; Fu L; Raja SM; Yue P; Khuri FR; Sun SY
Mol Cancer; 2010 Jan; 9():23. PubMed ID: 20113484
[TBL] [Abstract][Full Text] [Related]
18. Metformin sensitizes human bladder cancer cells to TRAIL-induced apoptosis through mTOR/S6K1-mediated downregulation of c-FLIP.
Zhang T; Wang X; He D; Jin X; Guo P
Anticancer Drugs; 2014 Sep; 25(8):887-97. PubMed ID: 24714080
[TBL] [Abstract][Full Text] [Related]
19. The BET bromodomain inhibitor, JQ1, facilitates c-FLIP degradation and enhances TRAIL-induced apoptosis independent of BRD4 and c-Myc inhibition.
Yao W; Yue P; Khuri FR; Sun SY
Oncotarget; 2015 Oct; 6(33):34669-79. PubMed ID: 26415225
[TBL] [Abstract][Full Text] [Related]
20. Amurensin G, a novel SIRT1 inhibitor, sensitizes TRAIL-resistant human leukemic K562 cells to TRAIL-induced apoptosis.
Kim HB; Kim MJ; Lee SH; Lee JW; Bae JH; Kim DW; Dao TT; Oh WK; Kang CD; Kim SH
Biochem Pharmacol; 2012 Aug; 84(3):402-10. PubMed ID: 22483777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]